Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
  • 1. Prevention
  • 2. Screening
  • 3. Diagnosis
  • 4. Treatment
  • 5. Person-Centred Perspective
  • 6. Research
  • 7. Appropriateness
  • 8. Long-term outcomes
  • Smoking prevalence
  • Smoking behaviours in current cancer patients
  • Smoking cessation
  • Second-hand smoke exposure
  • Geographic variation in lung cancer risk
  • Alcohol consumption
  • Adult overweight and obesity
  • Active transportation
  • Physical inactivity
  • Human papillomavirus (HPV) vaccination
  • Fruit and vegetable consumption
  • Geographic variation in colorectal cancer risk
  • Cervical cancer screening
  • Breast cancer screening
  • Colorectal cancer screening
  • PSA testing
  • Screening in underserved populations
  • Breast cancer diagnosis wait times
  • Colorectal cancer diagnosis wait times
  • Capture of stage
  • Stage distribution
  • Prostate risk profile
  • Surgery
  • Radiation therapy
  • Systemic therapy
  • Removal and examination of 12 or more lymph nodes in colon resections
  • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
  • The use of breast-conserving surgery versus mastectomies for breast cancer resections
  • Breast cancer resections that are mastectomies
  • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
  • Prostate wait times for surgery
  • Radical prostatectomy: open versus laparoscopic surgery
  • Radiation therapy wait times
  • Radiation therapy utilization and capacity
  • Pre-operative radiation therapy for patients with stage II or III rectal cancer
  • Post-operative radiation therapy for patients with stage I or II breast cancer
  • Prostate wait times for radiation therapy
  • Prostate patterns of care: radiation and surgical treatment
  • Post-operative chemotherapy for stage III colon cancer patients
  • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
  • Screening for distress
  • Patient satisfaction
  • Place of death
  • Prostate access to palliative radiation
  • Adult clinical trial participation
  • Prostate clinical trials participation
  • Pediatric clinical trial participation
  • Cancer research investment
  • Prostate cancer research investment
  • Breast cancer screening outside of guidelines
  • Breast cancer mastectomies done as day surgery
  • Intensive care use in the last two weeks of life
  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Prostate cancer
  • Pancreatic cancer
  • Five-year net survival by income quintile for several cancers in Canada
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Disease sites
  • Cervical
  • Cervical cancer screening

Cervical cancer screening

  • Charts and Tables

    Charts and Tables

    Figure 2.1

    Women aged 21-69 reporting at least one Pap test in 42-month period (%), by jurisdiction – 2010-13 screening years

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    “—” Data not available.

    Rate includes screens in the 42-month period January 1, 2010 - June 30, 2013.

    NB, ON: Data from January 2011 to June 2014.

    Age standardized to the 2011 Canadian population.

    Data source: Provincial and territorial cervical cancer screening programs

    Data Table

    JurisdictionPercent (%)
    BC73.8
    NL71.3
    MB70.8
    AB67.7
    PE67.4
    NS67.2
    NT67.2
    ON64.9
    NB64.5
    SK62.9
    YT–
    NU–
    QC–

    + Expand Table

    “—” Data not available.

    Rate includes screens in the 42-month period January 1, 2010 - June 30, 2013.

    NB, ON: Data from January 2011 to June 2014.

    Age standardized to the 2011 Canadian population.

    Data source: Provincial and territorial cervical cancer screening programs

  • Data specifications

    Data specifications

    The results were extracted from figure 1 in the report: Cervical Cancer Screening in Canada. Toronto (ON): Canadian Partnership Against Cancer; updated 2016 July. Details on methodologies can be found in the report.

  • Related indicators

    Related Indicators

    Human papillomavirus (HPV) vaccination

    Percentage of girls who received a full course† of human papillomavirus (HPV) vaccination from school-based HPV immunization programs, by province — most recent reported year
     Vaccination Uptake
    Jurisdiction School Grade School Year 1st dose (%) 2nd dose (%) 3rd dose (%)
    British Columbia 6 2016/17 — 66.5 Two-dose schedule
    Alberta 5 2016/17 76.0 — 66.7
    Saskatchewan Age 13 2016 75.7 71.9 61.4
    Manitoba 6 2015/16 69.0 62.2 Two-dose schedule
    Ontario 8 2015/16 71.3 61.0 Two-dose schedule
    Quebec 4 2016/17 81.2 76.0 Two-dose schedule
    New Brunswick 7 2016/17 79.0 74.7 Two-dose schedule
    Nova Scotia 7 2015/16 89.4 80.8 Two-dose schedule
    Prince Edward Island 6 2015/16 86.8 84.3 Two-dose schedule
    Newfoundland & Labrador 6 2015/16 — 92.0 Two-dose schedule
    Northwest Territories 7 2015/16 74.7 64.4 55.0
    Yukon 6 2016/17 84.7 66.5 Two-dose schedule
    Nunavut Grade 6 or ≥9 years old — — — —

    † As of the 2015/16 school year, the full course of vaccination for school-based HPV vaccination programs is three doses in AB, SK, NT and NU and two doses in all other provinces and territories.

    “—” Data not available.

    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow’s Health
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation